前列腺肿瘤标志物研究进展
摘要
近年来,对前列腺肿瘤标志物的研究不再局限于前列腺特异性抗原(PSA),随着检测技术的不断发展,GSTP1、PSCA、PSMA、TERT、PDEF等新型前列腺标志物不断出现,联合检测成为未来发展的方向。该文就此方面的研究进展作一综述。
出处
《国际检验医学杂志》
CAS
2006年第6期510-511,515,共3页
International Journal of Laboratory Medicine
参考文献13
-
1Mikolajczyk SD, Rittenhouse HG. Pro PSAz a more cancer specific form of prostate specific antigen for the early detection of prostate cancer. Keio J Med, 2003, 52(2): 86-91.
-
2Lin X, Asgari K, Putzi MJ, et al. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide. Cancer Res, 2001, 61(24): 8611-8616.
-
3Jeronimo C, Henrique R, Hoque MO, et al. A quantitative promoter methylation profile of prostate cancer. Clin Cancer Res,2004, 10(24): 8472-8478.
-
4Christiansen JJ, Rajasekaran SA, Moy P, et al. Polarity of prostate specific membrane antigen, prostate stem cell antigen, and prostate specific antigen in prostate tissue and in a cultured epithelial cell line. Prostate, 2003, 55(1): 9-19.
-
5Zhigang Z, Wenlv S. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues., implications for prostate carcinogenesis and progression of prostate cancer. Jpn J Clin Oncol, 2004,34(7): 414-419.
-
6Ross S, Spencer SD, Holcomb I, et al. Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate. Cancer Res, 2002, 62(9): 2546-2553.
-
7Ikegami S, Tadakuma T, Suzuki S, et al. Development of gene therapy using prostate-specific membrane antigen promoter/enhancer with Cre Recombinase/LoxP system for prostate cancer cells under androgen ablation condition. Jpn J Cancer Res, 2002, 93(10): 1154-1163.
-
8Todorova K, Ignatova I, Tchakarov S, et al. Humoral immune response in prostate cancer patients after immunization with genebased vaccines that encode for a protein that is proteasomally degraded. Cancer Immun, 2005, 5: 1.
-
9Iczkowski KA, Pantazis CG, McGregor DH, et al. Telomerase reverse transcriptase subunit immunoreactivity: a marker for high-grade prostate carcinoma. Cancer, 2002, 95(12): 2487-2493.
-
10Chieco P, Bertaccini A, Giovannini C, et al. Telomerase activity in touch imprint cell preparations from fresh prostate needle biopsy specimens. Eur Urol, 2001, 40(6): 666-672.
-
1沈英,冯麒,邹颂海.前列腺肿瘤标志物检测在前列腺疾病中的应用价值[J].放射免疫学杂志,2000,13(5):271-273.
-
2宋卫华,沈玉琴,郁超,郑兵.TSGF和tPSA联合检测在前列腺癌早期诊断中的应用[J].标记免疫分析与临床,2006,13(3):186-187. 被引量：2
-
3王刚,蒋先镇.Snail、PDEF在前列腺癌中的表达及其意义[J].中国男科学杂志,2009,23(10):21-25.
-
4沈嘉玲,袁维祥,刘智,李志明,姚怡婷.40岁以上正常男性血清PSA、fPSA/tPSA结果探讨[J].放射免疫学杂志,2011,24(2):224-225. 被引量：2
-
5张志才,邵增务.骨肉瘤新辅助化疗研究进展[J].现代肿瘤医学,2007,15(10):1515-1518. 被引量：5
-
6何乾,张国辉.前列腺肿瘤标志物的研究进展及临床意义[J].癌症进展,2017,15(1):7-9. 被引量：13
-
7汤京义.T—PSA、F—PSA及其比值在前列腺疾病鉴别诊断中的临床应用[J].医学检验与临床,2010(3):100-100.
-
8黄建华,许云飞,黄国华.PDEF及其与前列腺特异性抗原表达的关系[J].国际泌尿系统杂志,2006,26(2):190-193.
-
9刘敏,孙慧,刘贤锡.聚合酶链反应在前列腺癌诊断中的应用[J].生物医学工程研究,2004,23(2):125-127. 被引量：1
-
10吴拥军,吴逸明,王丽萍,相秉仁.对小细胞肺癌化疗药物的研究[J].药学进展,2000,24(5):281-284. 被引量：17
